Mikael Pihl

GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

Johnny Ludvigsson, Maria Faresjö, Maria Hjorth et al. · New England Journal of Medicine · 2008 · 516 citations · Full text

Medicine, Endocrinology, Immunology +16

GAD‐treatment of children and adolescents with recent‐onset type 1 diabetes preserves residual insulin secretion after 30 months

Johnny Ludvigsson, Mikael Chéramy, Stina Axelsson et al. · Diabetes/Metabolism Research and Reviews · 2013 · 41 citations

Medicine, Endocrinology, Pediatrics +16

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes

Stina Axelsson, Mikael Chéramy, Maria Hjorth et al. · PLoS ONE · 2011 · 40 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes

Hugo Barcenilla, Linda Åkerman, Mikael Pihl et al. · Frontiers in Immunology · 2019 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial

Stina Axelsson, Mikael Chéramy, Linda Åkerman et al. · Diabetes Care · 2013 · 35 citations · Full text

Life Sciences, Endocrinology, Immunology +15